Back to Sands Capital Alternatives, LLC
Sands Capital Alternatives, LLC
Q3 2026 13F filing
Updated 9 days ago24 disclosed positions worth $694.7M
Portfolio value
$694.7M
Total holdings
24
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-13
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A ALAMAR BIOSCIENCES INC | $144.1M | 4.23M | 20.75% | — |
| 2 | N NU HLDGS LTD | $88.5M | 6.99M | 12.74% | — |
| 3 | B BETA BIONICS INC | $75.9M | 4.00M | 10.92% | — |
| 4 | S SPYGLASS PHARMA INC | $65M | 2.50M | 9.36% | — |
| 5 | K KLAVIYO INC | $60.2M | 3.83M | 8.67% | — |
| 6 | T 10X GENOMICS INC | $43.5M | 481.8K | 6.27% | — |
| 7 | I INHIBIKASE THERAPEUTICS INC | $26.8M | 13.02M | 3.86% | — |
| 8 | C CEREBRAS SYSTEMS INC | $21.8M | 122.5K | 3.13% | — |
| 9 | D DOORDASH INC | $19.7M | 107.3K | 2.84% | — |
| 10 | O ODYSSEY THERAPEUTICS INC | $19.4M | 875.0K | 2.80% | — |
| 11 | F FREENOME INC | $18.9M | 1.20M | 2.73% | — |
| 12 | C COUPANG INC | $17.3M | 1.24M | 2.48% | — |
| 13 | D DATADOG INC | $17.3M | 63.0K | 2.48% | — |
| 14 | I SAMSARA INC | $15.1M | 395.6K | 2.17% | — |
| 15 | T TOAST INC | $9.1M | 314.9K | 1.31% | — |
| 16 | ? N/A ACUMEN PHARMACEUTICALS INC | $8.3M | 3.72M | 1.19% | — |
| 17 | S SNOWFLAKE INC | $7.8M | 22.9K | 1.12% | — |
| 18 | T TARSUS PHARMACEUTICALS INC | $6.7M | 85.0K | 0.96% | — |
| 19 | T SERVICETITAN INC | $6M | 91.1K | 0.86% | — |
| 20 | B BIOAGE LABS INC | $5.6M | 786.4K | 0.80% | — |
| 21 | M MONDAY COM LTD | $5.3M | 67.2K | 0.76% | — |
| 22 | ? N/A ACRIVON THERAPEUTICS INC | $4.7M | 2.29M | 0.68% | — |
| 23 | C CANDEL THERAPEUTICS INC | $4.2M | 405.8K | 0.61% | — |
| 24 | T TAYSHA GENE THERAPIES INC | $3.5M | 724.9K | 0.51% | — |